Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 4 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 63 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 11 most recent Form 4 transactions.
| Jul 1 | TAK | Takeda Pharmaceutical Co… | AGRANT | 3,800 | — | — | +57.6% | Open the original filing on SEC.gov |
| Jun 24 | KYMR | Kymera Therapeutics, Inc. | AGRANT◆ | 6,068 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | RAPP | Rapport Therapeutics, Inc. | AGRANT◆ | 15,200 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | BEAM | Beam Therapeutics Inc. | AGRANT◆ | 19,676 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 817 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 817 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 17,974 | — | — | +100.0% | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 17,974 | — | — | — | Open the original filing on SEC.gov |
| Jan 29 | COAG | Hemab Therapeutics… | AGRANT◆ | 107,338 | — | — | — | Open the original filing on SEC.gov |